> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# BIMO Inspection Violation in India Hospital
- URL: https://www.fdaweb.com/bimo-inspection-violation-in-india-hospital/
- Published: 2026-01-13T12:00:00.000Z
- Updated: 2026-09-14T15:30:29.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5160476

A 1/20-1/24/2025 FDA Bioresearch Monitoring Program inspection at Senthil Specialty Hospital in Pondicherry, Puducherry, India, found that Dr. **Purushothaman Kumaran** failed to ensure that a clinical in vivo bioequivalence study was conducted according to the investigational plan. A just-released 12/22/2025 [Warning Letter](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/purushothaman-damodara-kumaran-md-721325-12222025?ref=fdaweb.com) says Kumaran’s response to the inspection observation was inadequate because it did not provide information about any completed or proposed corrective actions that would prevent similar violations in the future.

Kumaran was told to respond with a list of specific steps taken to prevent similar violations in the future.